Skip to main content

ProShare Advisors LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1357955 BETHESDA, MD

Position in REGN

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$74,350,909
-$43,397,109 QoQ
Shares Held
119,240
-21.8% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#102
of 1,327 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. REGN ranks #2 (22.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
119,240 $74,350,909

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $74,350,909 119,240
2026-03-31 $117,748,018 152,397
2025-12-31 $142,244,834 184,286
2025-09-30 $75,993,039 135,154
2025-06-30 $88,905,075 169,343
2025-03-31 $103,564,685 163,292
2024-12-31 $104,096,344 146,135
2024-09-30 $126,271,795 120,117
2024-06-30 $118,988,157 113,211
2024-03-31 $120,506,635 125,203
2023-12-31 $90,989,965 103,599
2023-09-30 $100,089,218 121,621
2023-06-30 $78,060,029 108,637
2023-03-31 $94,054,921 114,468
2022-12-31 $75,525,573 104,680
2022-09-30 $82,391,607 119,604
2022-06-30 $84,494,939 142,938
2022-03-31 $144,667,226 207,135
2021-12-31 $136,450,631 216,067
2021-09-30 $92,104,159 152,193
2021-06-30 $75,817,895 135,743
2021-03-31 $66,260,418 140,044
2020-12-31 $58,462,590 121,013
2020-09-30 $58,508,205 104,520
2020-06-30 $53,560,309 85,882
2020-03-31 $36,095,861 73,923